SIRT Versus cTACE for Unresectable HCC (CHANCE2506)

Clinical trial NCT06909708 · RECRUITING

Trial details

NCT number: NCT06909708
Sponsor: Zhongda Hospital
Status: RECRUITING
Phase: Not Applicable
Study type: INTERVENTIONAL

Unresectable Hepatocellular Carcinoma

Start date: 2025-04-03
Primary completion: 2026-12-31
Enrollment: 108

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.